Pilot and Feasibility Grants
Funding opportunities for IBD and digestive disease research.
Pilot and Feasibility Program Funding Opportunities
Now in its 29th year, the CSIBD promotes the research of both basic and clinical scientists in a wide range of areas. These include, but are not limited to:
- Exploratory Studies for Delineating the Microbiome in Human Health (including bacterial-epithelial cell interactions and host responses to commensal versus invasive luminal flora)
- Epithelial Cell Biology (including regulation of stem cells, epithelial cell polarity, and membrane biology)
- Tissue Immunity (including mucosal immunology, innate immune recognition, antigen presentation and adaptive immunity, fibrosis, and single-cell analysis)
- Monitoring Effects of Immunotherapy and Biologic Therapy in Autoimmunity
- Translational Human Immunology (including autoimmune diseases, GI cancers, and IBD)
- Signaling Pathways in Gut-Brain Communication
Goals
Funds have been made available to support Pilot and Feasibility Program grants consistent with the overall goals of the Center. The goals of the CSIBD's Pilot and Feasibility Program are to support the following:
- Young investigators (senior fellows* or junior faculty) working in areas that will improve our understanding of basic processes relevant to inflammatory bowel disease
- Established investigators initiating a new area of research in their laboratories relevant to mechanisms underlying inflammatory bowel disease
The objective of a Pilot and Feasibility Program grant is to enable an investigator to complete sufficient preliminary studies to enable successful application for more substantial funding from other sources. Pilot and Feasibility Program grants are not intended to supplement ongoing or currently funded projects. Participation in another digestive disease center precludes eligibility for these grants.
* Fellow must be in the final year of training and must have a documented commitment to a faculty appointment by the sponsoring unit or department.
Funding
The CSIBD will fund three awards of up to $35,000 each (direct costs) through this program. Pilot and Feasibility Program grants are made for a one-year period; a second year will be considered on a competing basis. Awards made to institutions other than MGH will not receive indirect costs.
Applications
Pilot and Feasibility Program grant applications can be downloaded from the links below or obtained from Lindsay Ware (lware@mgh.harvard.edu). The deadline for receipt of applications is July 29, 2020.
Other Funding Sources
Follow the links below to find information about other funding opportunities.
Recipients of Previous Pilot and Feasibility Program Awards
| 2020 |
Hilary Finucane, PhD Schmidt Fellow Hailiang Huang, PhD Instructor of Medicine |
| 2019 |
Tami Lieberman, PhD Assistant Professor, Institute for Medical Engineering and Science Caroline Sokol, MD, PhD Assistant Professor of Medicine Alexandra-Chloe Villani, PhD Assistant Professor of Medicine |
| 2018 |
Sabina Islam, MD Assistant Professor of Medicine James Moon, PhD Assistant Professor of Medicine David Drew, PhD Instructor in Medicine Gaurav Gaiha, MD, PhD Instructor in Medicine |
| 2017 |
Michael Dougan, MD, PhD Instructor in Medicine Russell Goodman, MD, PhD Instructor in Medicine Aylwin Ng, PhD Assistant Professor of Medicine |
| 2016 |
Kate Jeffrey, PhD Assistant Professor of Medicine Hamed Khalili, MD, PhD Assistant Professor of Medicine Alan Mullen, MD, PhD Assistant Professor of Medicine |
| 2015 |
Robert Anthony, PhD Assistant Professor of Medicine Timothy Lu, MD, PhD Associate Professor of Biological Engineering and Electrical Engineering and Computer Science Deanna Nguyen, MD Assistant Professor of Medicine Jolan Walter, MD, PhD Assistant Professor of Pediatrics Omer Yilmaz, MD, PhD Assistant Professor of Biology |
| 2014 |
John Garber, MD Instructor in Medicine Kate Jeffrey, PhD Instructor in Medicine Stanley Shaw, MD, PhD Assistant Professor of Medicine Omer Yilmaz, MD, PhD Assistant Professor of Biology |